| INTRODUCTION
Approximately, one-third of patients with Crohn's disease (CD) will develop a perianal fistula in their lifetime. 1, 2 This relatively common disease complication is associated with significant morbidity and substantially impaired quality of life. Medical therapy is only partially effective, such that patients frequently undergo surgery to control symptoms and disease-related complications. Therefore, more effective treatment approaches are needed that will require evaluation in well-designed randomised controlled trials.
In this respect, the lack of a robust and validated outcome measure has constrained research in this area. In clinical practice, pelvic magnetic resonance imaging (MRI) has an established role for the evaluation of patients with perianal fistulas and is used to make clinical decisions and assess changes in disease state. 3, 4 While several scoring systems, such as the Fistula Drainage Assessment and the partially validated Perianal Disease Activity Index, have been used to quantify clinical parameters, far fewer have been developed for MRI and they also lack standardised definitions of descriptor items. 5 The most frequently used MRI index is the Van Assche index, originally developed to fulfil the need for an instrument that could measure response of perianal fistulising CD to medical therapy. 6 The components of the index, based primarily upon radiological expertise and the classification of perianal fistulas by Parks et al., were shown to be reliable in the initial small (n=18) study. 6, 7 In a subsequent small study, in addition to was not assessed due to sample size limitations, and no conclusions could be made on the value of the additional inflammatory components. 8 Ng et al. also found the total Van Assche index partially responsive to change with treatment with anti-tumour necrosis factor therapy, although they did not examine the operating properties of the individual index items and it was evident that the overall index was insensitive to change in some patients, including those with a 50%-80% reduction in track volume. 9 In 2013, the World Congress of Gastroenterology working group formulated a multi-disciplinary consensus statement for classifying, diagnosing, and treating fistulising CD and identified the need for a validated index for measuring response to therapy as a high priority. 10 In the first steps towards this goal, we: (1) devel- 
| MATERIALS AND METHODS

| Study population
Fifty MRI scans carried out in 50 patients with active perianal fistulising CD between July 2011 and November 2013 at the Academic Medical Centre, Amsterdam, The Netherlands were evaluated. The sample included a wide range of disease complexity and anatomical classification (Table S1 ). The indications for which the scans were performed included active perianal symptoms and evaluation of response to previous medical or surgical interventions. Scans with missing sequences, and those from patients who did not receive intravenous contrast due to allergy or who had undergone ileoanal pouch formation for colonic CD were excluded ( Figure S1 ). Of the 50 scans, 45 were collected in a consecutive manner with a further five scans hand-selected to ensure that all of the fistula classifications were represented in our cohort. These additional scans were selected based on the description of the reporting radiologist for the purposes of clinical practice, and were not selected by the expert central readers and had not been previously reviewed by the readers for other purposes. These scans included intersphincteric, extrasphincteric, suprasphicteric and two transsphincteric fistulas. One of these was considered complex. Ideally, more of the less commonly occurring fistula subtypes would have been included in our final set of scans but they, by their very nature, occur infrequently and were therefore difficult to identify.
| MRI acquisition technique
MRI scans were performed on a 1.5-T scanner (Magnetom Avanto, Siemens, Erlangen, Germany) according to a standardised protocol for perianal fistulising disease, consisting of the following sequences:
T2-weighted turbo spin echo (TSE) sequences in the sagittal, coronal and transverse plane, a fat-saturated T2-weighted TSE spectral adiabatic inversion recovery sequence and a post-contrast fat-saturated T1-weighted TSE sequence in the transverse plane (Table S2) . A combination of saturated and unsaturated T2 sequencing was used to discriminate between fibrosis, oedema and fat.
The post-contrast sequences were performed 60 seconds after intravenous administration of 0.1 mL/kg gadobutrol (Gadovist 0.1 mmol/mL, Bayer Schering Pharma, Berlin, Germany). The coronal and axial sequences were parallel and orthogonal to the anal sphincter axis, respectively. A spasmolytic agent (Buscopan, Boehringer
Ingelheim, Ingelheim, Germany) was used to reduce bowel peristalsis and motion artifacts. All MRI examinations were anonymised and uploaded to a secure central viewing system.
| Scoring conventions and modification to the original Van Assche index
Based upon face validity and expert opinion of radiologists in this field (CS, CYN, JR, JS, SAT), we developed standardised scoring
conventions for component items of the original Van Assche index, and included additional descriptors to these items as modifications.
We also incorporated novel items considered potentially important based on face validity that might also be responsive to change after a therapeutic intervention through the same expert opinion process.
A pilot study followed whereby four expert abdominal radiologists (CS, CYN, JR, SAT) with experience in fistula MRI evaluated four scans (that were not subsequently included in the 50 study scans), before refining the items/descriptors during subsequent discussion, which took place prior to initiation of the reliability study. These discussions were conducted in a manner consistent with a Delphi process although no formal voting was carried out. The adapted version of the Van Assche index is henceforth referred to as the modified Van Assche index.
| Reliability study
Four expert abdominal radiologists (CS, CYN, JR, SAT) with experience in fistula MRI and blinded to clinical information independently reviewed 50 MRI examinations in triplicate in random order and assessed disease activity using both the original and the modified Van Assche index ( Table 1) .
The study radiologists also completed three visual analogue scale (VAS) assessments for each scan as part of their evaluations. The first was aimed at evaluating the overall severity of the inflammatory component of the perianal disease (0 mm=no active inflammatory disease, 100 mm=severe active inflammatory disease). The second assessed the overall complexity (0 mm=minimal complexity, 100 mm=highly complex). The final VAS assessment was a combined global assessment that took account of both inflammatory activity and complexity (0 mm = no perianal disease, 100 mm = worst perianal disease encountered), and was the score used as the gold standard comparator. In addition, the presence or absence of imaging artifacts was recorded, as was image quality, using a three-point scale (good, adequate, inadequate).
Intra-and inter-rater reliability statistics were calculated and com- "fair," "moderate," "substantial" and "almost perfect" reliability, respectively, were subsequently discussed during a second consensus meeting of the study radiologists. Consensus statements were generated during this meeting, and RAND appropriateness methodology was used to refine items accordingly. 11 RAND appropriateness methodology uses a modified Delphi panel approach to combine the best available evidence and personal clinical experience of experts.
The panel facilitates decision-making through an iterative process in which questions are raised and viewpoints discussed. Experts then vote on the appropriateness of statements developed during this process with an aim to reach consensus according to predefined criteria. As part of the process, rules were developed that would improve consistency of reading of MRI images of perianal fistulas.
Other potential sources of disagreement among the radiologists were explored by identifying "outlier" images that led to the poorest inter-rater reliability. These outlier images were reviewed by one expert reader (JS) for potential common sources of variance.
| Statistical methods
Clinical characteristics were assessed using descriptive statistics.
Intra-and inter-rater reliability were quantified using intraclass correlation coefficients (ICCs), which are equivalent to weighted Kappa statistics in the case of ordinal data. 12 For each component item, point estimates of intra-and inter-rater ICCs were concurrently estimated using a two-way random effects model with interaction. This approach is commonly known as the cluster bootstrap method. 14 The degree of reliability was interpreted based on Landis and Koch benchmarks. These empirical benchmarks were originally developed for grading kappa statistics and have now become widely adopted for assessment of ICCs.
The modified Van Assche index was created using the VAS for global assessment of severity as the outcome criterion. To account for the data structure that each MRI scan was read three times by each of the four readers, a mixed effects model was adopted with fixed effects 
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3 | RESULTS
| Modified Van Assche index
Scoring conventions, modifications, and addition of novel items to the original Van Assche index based upon the expert consensus to Table 1 . Core items from the Van Assche index were all retained, although the "Collections" item was modified and incorporated into a new item "Inflammatory mass" as described in Table 1 The original van Assche index consists of six anatomical and (weighted) inflammatory disease parameters including assessment of; the numbers of fistula tracts (0-3), the location of fistulas (1-3), extension of fistulas (1 or 2), hyperintensity on T2-weighted images (0, 4, or 8), presence of collections (defined as cavities >3 mm in diameter) (0 or 4) and rectal wall involvement (score 0 or 2). The total score ranges from 0 to 22. For the modified index, extensions were also assessed and the most severe lesion was rated by comparing signal intensity with nearby, in-plane vessels; images were fat saturated.
the primary tract or extensions on post-contrast fat-saturated T1-weighted images; (4) assessment of the dominant feature of the primary tract and extensions.
| Participant characteristics
Participant demographics are outlined in Table S3 . The mean age of the patients was 39 (range, 19-75 years), 48% (24/50) were male, the mean CD disease duration was 14 years (range, 0.5-47 years) and the mean duration from first fistula diagnosis was 9 years (range, 1 month-39 years). Most participants had prior perianal surgery (66%), and more than half (56%) were under treatment with an anti-tumour necrosis factor (TNF) agent. The mean overall assessment of disease severity based on the VAS was 4.36 (range 0.20-9.80).
| MRI image quality
A total of 600 reads were performed by the four expert radiologists.
Of these, 565 (94.2%) were considered to be of good quality, 30 (5.0%) were adequate and 5 (0.8%) were considered inadequate.
Only 2.2% of reads reported a missing sequence or plane and imaging artefact was present in 5%. Four cases contained anovaginal fistulas.
| Reliability results for overall indices
Intraclass correlation coefficients and 95% confidence intervals (CI) for intra-and inter-rater reliability for scoring of the VAS and the total original and modified Van Assche indices and their components are shown in Table 2 .
While almost perfect intra-rater reliability was observed for all of the VAS-based assessments, inter-rater reliability ranged from moderate to substantial. The lowest inter-rater ICC was observed for assessment of complexity of disease (0.41, 95% CI, 0.28-0.51), fol- Table 2 and Table S4) (Table 2 and Table S4) 
| Sources of disagreement and consensus process
The consensus process, which involved participation of four experts (CAJP, ST, JR, JS), a gastroenterologist (GDH) and a moderator (VJ) was conducted using RAND appropriateness methodology to review items contributing to the greatest variance in an attempt to understand and minimise the sources and improve inter-rater reliability. In addition, nine MRI scans responsible for the greatest disagreement based on their effect on the overall estimation of ICCs were reviewed by a single expert reader (JS) to identify features that may have contributed to disagreement. As a result of this process, modifications were made to four specific items. Subsequently, readers voted on the appropriateness of the modified items (Table S5 ). The recommendations of the experts and the proposed modified items are described in Table 3 and Table S6 .
| Final modified van Assche index based on mixed effects modelling
The mixed effect model building process began with all nine items described in Table 1 . Coefficient estimates and associated inferential statistics for these items are shown in Table 4 . Negligible and statistically insignificant coefficients were observed for number of fistula tracts and location, and presence of a recto/anovaginal tract and hyperintensity on post-contrast T1-weighted images were only marginally significant (P=.053 and .051 respectively). The model was then refitted with the remaining five component items, resulting in numerically large and statistically significant coefficients (Table 4 ). The final modified Van Assche index based on mixed effects modelling included "extension," "hyperintensity on T2-weighted images," "rectal wall invovlement," "inflammatory mass,"
and "dominant feature of primary tract and extension". Intra-class correlation coefficients for intra-and inter-rater reliability of the This item and definition should replace rectal wall involvement (see Table 1 for original item and definition). 16 In clinical practice, MRI has an essential role in the assessment of perianal disease and thus development of a fully validated MRI-based evaluative instrument with well-defined operating properties is essential for both for the evaluation of clinical disease activity and for the efficient study of new treatments in clinical trials. Besides the Van Assche index, to our knowledge, the only other previously described MRI index for assessment of the severity of perianal disease is the index described by Ng and colleagues. 9 In their study, as well as highlighting that the van Assche index was insensitive to change in some patients in whom there was radiological evidence of fistula improvement, Ng et al. also semi-quantitatively described within-patient fistula changes in response to therapy as "healed (absence of high-signal tracks on fat-saturated T2 sequences)" or "improved," "unchanged," or "worse" in cases where fistula tracks remained visible. Both indices have been used to define endpoints in clinical trials despite the lack of a complete characterisation of their operating properties or standardised methods for scoring. These limitations informed the need for our study. A critical step in index development is to determine the reliability of index component items, which is defined as the extent to which raters are able to consistently distinguish between study subjects and the degree to which repeated measurements provide similar results. 17 We found "almost perfect" intra-rater reliability for the original Van Assche index, and "substantial" reliability for all of the individual component items with the exception of fistula location. In contrast, the corresponding inter-rater reliability was lower, and ranged from slight to substantial, with the lowest reliability inter-rater performance and attempted to improve them by developing and including standardised scoring conventions and modifications through a systematic consensus process. Specifically, the inter-rater reliability of "location" and "extension," were substantially improved (see Tables 1 and 2 ). For assessment of fistula extension, the experts felt that definition of the ano-rectal junction was a potential source of disagreement among readers. Two cases with considerable variability for the identification of supravs infralevatoric extensions are shown in Figures 1 and 2 . To provide superior differentiation between these extensions, we defined the ano-rectal junction as the connection of the levator plane to the ano-rectum. This anatomical location is delineated by a two arrows in Figure 3 .
Despite the application of scoring conventions and inclusion of an additional item (increased signal intensity), ICCs for inter-rater reliability for the assessment of rectal wall involvement decreased marginally in the modified Van Assche index. Poor rectal distension and subjectivity in discerning signal intensity relative to surrounding planes were potential sources of disagreement considered by the experts. Although this item remained significant in the mixed effects modelling approach, it was re-named as "absence or presence of proctitis" and re-defined based on the expert RAND consensus to improve reliability (Table S6 ). The proctitis item is a composite score of several features that had fair inter-rater reliability in this study. However, improved inter-rater reliability (with the exception of fair to moderate inter-rater reliability for perimural enhancement) was observed in a separate recently published study on individual MRI features in Crohn's proctitis that were significantly correlated with endoscopy. 18 As the inter-rater reliability of this item was not tested in this study, it may be worthwhile to further explore a more detailed evaluation of proctitis. No standardised definitions or modifications were initially applied to the item "number of fistula tracts," since this assessment was considered to be self-explanatory. It was thus somewhat unexpected that only "fair" inter-rater reliability was observed for this item. We subsequently modified this item to include the descriptors "single, unbranched" or "complex" based on expert opinion regarding the difficulty associated with differentiating a single tract with multiple braches, from disease with multiple tracts, although this item was not statistically significant in the mixed effects model building, and
was not included as an item in the final index. 
The ano-rectal junction. To provide superior differentiation between supra-and infralevatoric extensions, this junction is now defined as the connection of the levator plane to the ano-rectum and is delineated by two arrows in this coronal oblique T2-weighted image
Inter-rater reliability for the novel items included in the modified Van Assche index ranged from slight-to-moderate. Modifications to further improve reliability are shown in Table S6 . Although there was no expert consensus on the appropriateness of the inclusion of the absence or presence of an ano/rectovaginal this item was not statistically significant in the mixed effects model building and was excluded from the final index. The relatively poorer inter-rater reliability for this item was thought to be likely due to the difficulty associated with identifying these tracts, which are typically short in length, small in diameter and obscured between vessels. Free drainage to the vagina and rectum, and lack of fluid within the tract were also thought to contribute to difficulty in identification of these tracts.
Limitations of our study should be acknowledged. First, images for the study were acquired from a tertiary centre, which is a regional centre for complex cases. Accordingly, some of the MRI's reviewed were considered to represent severe disease, where complexity is likely to be higher than the general IBD population. However, the MRI scanners, sequences and protocols used in this study are consistent with those used in most centres. This study did not include diffusion weighted imaging and its potential added value to the protocol performed in this study has not yet been clearly demonstrated. Second, the scans were carried out for a range of indications and included patients who were receiving various treatments, including anti-TNF agents. It is possible that these factors could have introduced bias (for example, attenuation of inflammatory activity due to treatment effect). Conversely, this heterogeneity may also serve to increase the generalisability of our results as many MRI assessments are performed in patients receiving anti-TNF therapy.
Third, while the quality of the majority of MRI images was judged to be acceptable, the method by which we evaluated quality (good, adequate or inadequate) was subjective and did not include standardised definitions. Fourth, readers were highly experienced IBD radiologists and thus the results may not be generalisable to other readers; however, since the objective of this exercise was to refine operating characteristics of an existing MRI fistula scoring system for use in clinical trials, this situation mandated the need for specialist radiologists. Fifth, we acknowledge that the number of scans included was modest (n=50), however, the total number of reads was substantial (n=600), owing to the reading of scans in triplicate by all four radiologists which was, by design, based upon formal statistical methods for a reliability study. Finally, we were unable to test the responsiveness of the new index, which would require comparing baseline and post-treatment MRI's in patients receiving a treatment of known efficacy, ideally in a randomised, placebo-controlled trial. Once such a dataset becomes available, the responsiveness of the modified van Assche index can be tested and a minimally important score change identified. Furthermore, it has not escaped our attention that MRI-defined disease activity may be an important prognostic indicator since it provides relevant information about deep-tissue inflammation and healing and may provide important information about progressive structural damage. Nevertheless, several questions remain about the optimal timing for MRI assessment, with preliminary data indicating that this may be considerably longer than traditional clinical or endoscopic follow-up periods. 9 In conclusion, we found "substantial" to "almost perfect" intrarater reliability among radiologists in the assessment of fistulising perianal CD using the modified Van Assche index, but only "slight"
to "moderate" inter-rater reliability. Standardised scoring definitions and modifications to the van Assche index developed through a consensus process enabled us to characterise the greatest sources of disagreement, thus generating recommendations that may improve inter-rater reliability. The modified van Assche index derived through a mixed effects modelling approach has the potential for use in routine clinical practice to more consistently assess changes in disease acitivity, as well within clinical trials to evaluate new therapies.
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